홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /화합물

프로스타글란딘D2

Prostaglandin D2

HCID 448457
새 노트새 반응견적 요청하기
인쇄 미리보기

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
41598-07-6
표준 SMILES
CCCCC[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O
InChIKey
BHMBVRSPMRCCGG-OUTUXVNYSA-N
분자식
C20H32O5
평균 분자량
352.5 g/mol
단동위원소 질량
352.22497412

이름 및 식별자

우선 이름
Prostaglandin D2
IUPAC
(Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid
현지명
프로스타글란딘D2
영어명
PROSTAGLANDIN D2
분자식
C20H32O5
분자량
352.47

이름 및 동의어

prostaglandin D2PGD241598-07-611-Dehydroprostaglandin F2-alphaBRN 217062311-Dehydroprostaglandin F2alphaRXY07S6CZ211-Dehydroprostaglandin F2 alphaDTXSID30897162(Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid(5Z,13E,15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate(5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate
이름 더 보기
프로스타글란딘D2PGDSProstaglandin D?PROSTAGLANDINS D22PROSTAGLANDIN D2PGD2 (Prostaglandin D2)RP23-47P18.11-006, 21kDa11-dehydroprostaglandinf2-alpha
9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acidCHEBI:15555(5Z,13E,15S)-9alpha,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic acidProsta-5,13-dien-1-oic acid, 9,15-dihydroxy-11-oxo-, (5Z,9-alpha,13E,15S)-D2, Prostaglandin11 Dehydroprostaglandin F2alpha11 Dehydroprostaglandin F2 alphaF2alpha, 11-Dehydroprostaglandin

데이터베이스 식별자

CAS
41598-07-6
PubChem CID
448457
DTXSID
DTXSID30897162
ChEMBL
CHEMBL1235252
ChEBI
CHEBI:15555
UNII
RXY07S6CZ2
EC Number
636-995-9
Nikkaji
J16.416J

물성

구조 계산 물성보충 중

XLogP
2.6
극성 표면적
94.8 Ų
수소 결합 공여자 수
3
수소 결합 수용자 수
5
회전 가능 결합 수
12
무거운 원자 수
25
형식 전하
0
복잡도
469

실험 및 물리화학적 성질

Melting Point56 - 57 °C
Physical DescriptionSolid
Collision Cross Section · 3건

196.63 Ų [M+Na]+ [CCS Type: DT; Method: stepped-field]

192.4 Ų [M+Na]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)];186.17 Ų [M-H2O-H]- [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

189.4 Ų [M-H]-;195.4 Ų [M+Na]+

물리화학적 성질

녹는점
68 °C · 68°C
끓는 점
406.07 °C · 406.07°C (rough estimate)
밀도
1.0601 · 1.0601 (rough estimate)
굴절률
1.612 · 1.6120 (estimate)
저장 조건
-20 °C · -20°C
용해도
클로로포름 (약간 용해됨), 에탄올 (약간 용해됨), 메탄올 (약간 용해됨), THF (약간 용해됨)
물리적 상태
흰색 고체
산도 계수 (pKa)
4.76 · 4.76±0.10(Predicted)
색상
흰색에서 밝은 주황색까지
생물학적 소스
synthetic

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 5건

Danger

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral];H360 (100%): May damage fertility or the unborn child [Danger Reproductive toxicity]

P203, P264, P270, P280, P301+P317, P318, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 4 (100%);Repr. 1B (100%)

안전 데이터

wgk
3
rtecs
UK7930000
risk_code
60-22
hazard_code
T
safety_code
53-22-26-36
F 고인화성물질
10
Hazard Classifications
Acute Tox. 4 OralRepr. 1B
스토리지 클래스
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects

화학 및 산업

약리 정보

Tissue LocationsAdipose Tissue;Brain;Epidermis;Liver;Neuron;Platelet;Smooth Muscle;Spleen
Cellular LocationsCytoplasm;Endoplasmic reticulum;Extracellular;Membrane
Metabolite Pathways · 1건

Acetaminophen Action Pathway;Acetylsalicylic Acid Action Pathway;Antipyrine Action Pathway;Antrafenine Action Pathway;Arachidonic Acid Metabolism;Bromfenac Action Pathway;Carprofen Action Pathway;Celecoxib Action Pathway;Diclofenac Action Pathway;Diflunisal Action Pathway;Total 43 pathways, visit the HMDB page for details

응용 분야 · 2건

개요Prostaglandin D2 (PGD2) is the major eicosanoid product of mast cells and is released in large quantities during allergic and asthmatic anaphylaxis. Mastocytosis patients produce excessive amounts of PGD2, which causes vasodilation, flushing, hypotension, and syncopal episodes. PGD2 is also produced in the brain via an alternative pathway involving a soluble, secreted PGD-synthase also known as β-trace. In the brain, PGD2 produces normal physiological sleep and lowering of body temperature. Further pharmacological actions include inhibition of platelet aggregation and relaxation of vascular smooth muscle. PGD2 inhibits human ovarian tumor cell proliferation with an IC50 of 6.8 μM.

용도Prostaglandin D2 is a fatty acid compound present in the human body. Elevated levels of localized Prostaglandin D2 has been linked to hair loss and growth inhibition. It has also been seen to contribute to the activity of allergic asthma.

상·하류 제품 정보

상류 원료

Prosta-5,13-dien-1-oic acid, 9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-15-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-11-oxo-, (5Z,9α,13E,15S)- (9CI)

관련 반응

24건
반응 기록 만들기
HRID 6685 반응식
HRID 6685생성물로uspto-grants-2006_08
HRID 258641 반응식
HRID 258641반응물로uspto-grants-1977_07
HRID 258642 반응식
HRID 258642생성물로uspto-grants-1977_07
HRID 328229 반응식
HRID 328229반응물로uspto-grants-1977_04
HRID 328230 반응식
HRID 328230생성물로uspto-grants-1977_04
HRID 436951 반응식
HRID 436951생성물로uspto-grants-1977_06
HRID 457460 반응식
HRID 457460생성물로uspto-grants-2007_03
HRID 477215 반응식
HRID 477215생성물로uspto-grants-1989_12
1 / 3 페이지

화합물 노트

불러오는 중…

이 페이지에서기본 정보이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
더보기
새 노트새 반응견적 요청하기
BRN
2170623 · 2170623
안정성
감광성
InChIKey
BHMBVRSPMRCCGG-OUTUXVNYSA-N
SMILES
[H][C@]1(C\C=C/CCCC(O)=O)[C@@H](O)CC(=O)[C@]1([H])\C=C\[C@@H](O)CCCCC
Prosta-5,13-dien-1-oic acid, 9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-15-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-11-hydroxy-, (5Z,9α,11α,13E,15S)- (9CI)
Prosta-5,13-dien-1-oic acid, 9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-15-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-11-hydroxy-, methyl ester, (5Z,9α,11α,13E,15S)- (9CI)
Prosta-5,13-dien-1-oic acid, 9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-15-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-11-[(tetrahydro-2H-pyran-2-yl)oxy]-, methyl ester, (5Z,9α,11α,13E,15S)- (9CI)
Prosta-5,13-dien-1-oic acid, 15-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-9-hydroxy-11-[(tetrahydro-2H-pyran-2-yl)oxy]-, methyl ester, (5Z,9α,11α,13E,15S)- (9CI)
5-Heptynoic acid, 7-oxo-, methyl ester
2H-Pyran, tetrahydro-2-[[(1S)-1-[(1E)-2-iodoethenyl]hexyl]oxy]-
(4R)-(+)-T-부틸디메틸실록시-2-CYCLOPENTEN-1-ONE

추가 설명

정의ChEBI: A member of the class of prostaglandins D that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9 and 15 and an oxo group at position 11 (the 5Z,9alpha,13E,15S- s ereoisomer).